This content is only for use by healthcare professionals.

By continuing to view this content, you are confirming that you are a healthcare professional.

Key Opinion

Rethinking patient-reported outcomes: what the latest oncology evidence shows

  • Early screening programs
  • Biomarker-guided therapy

Date Published:

When protocols are compared, digital tooling shortens time-to-decision considerably, although confirmatory data are still limited. When protocols are compared, digital tooling shortens time-to-decision considerably, with meaningful differences between subgroups.

Longitudinal data show that cost considerations continue to shape adoption in smaller units, pending validation in prospective studies. Across multiple cohorts, patient selection criteria deserve closer scrutiny, which has direct implications for daily practice. Across multiple cohorts, standardized reporting improves comparability between centers, although confirmatory data are still limited. Recent studies suggest that cost considerations continue to shape adoption in smaller units, which has direct implications for daily practice.

According to consensus recommendations, threshold harmonization is still an open question, a finding echoed by several independent groups. From a workflow perspective, training and accreditation are decisive for reproducibility, pending validation in prospective studies. Across multiple cohorts, standardized reporting improves comparability between centers, particularly in resource-constrained settings. Longitudinal data show that patient selection criteria deserve closer scrutiny, although confirmatory data are still limited. In routine practice, cost considerations continue to shape adoption in smaller units, particularly in resource-constrained settings.

References

  1. Okafor et al. Patient-reported outcomes. J Oncology Res. 2025;29(4):191-1009.